Compare Stocks → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:INNTNASDAQ:KMPHNASDAQ:SNNA Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINNTInnovate Biopharmaceuticals$0.97$0.37▼$1.67$8K-0.39525,982 shs253 shsKMPHZevra Therapeutics$5.51$4.00▼$6.92$200.47M2.16189,500 shs64,100 shsSNNASienna Biopharmaceuticals$0.14$0.14$0.06▼$3.80$4.20M2.671.87 million shs13.32 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINNTInnovate Biopharmaceuticals0.00%0.00%0.00%0.00%-99.92%KMPHZevra Therapeutics0.00%0.00%0.00%0.00%0.00%SNNASienna Biopharmaceuticals0.00%0.00%0.00%0.00%0.00%[BUY ALERT] Our #1 A.I. Stock for March (Ad)It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>>MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationINNTInnovate BiopharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AKMPHZevra TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ASNNASienna BiopharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINNTInnovate BiopharmaceuticalsN/AN/AN/AN/AKMPHZevra TherapeuticsN/AN/AN/AN/ASNNASienna BiopharmaceuticalsN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINNTInnovate BiopharmaceuticalsN/AN/AN/AN/A($0.27) per shareN/AKMPHZevra Therapeutics$10.72M0.00N/A23.28$3.63 per share0.00SNNASienna BiopharmaceuticalsN/AN/AN/AN/A$1.27 per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINNTInnovate Biopharmaceuticals-$27.05MN/AN/AN/AN/AN/AN/A-234.42%N/AKMPHZevra Therapeutics-$8.56MN/A0.00N/AN/A-328.56%-16.12%-14.17%N/ASNNASienna Biopharmaceuticals-$73.47M-$3.59N/AN/AN/AN/A-177.36%-52.22%N/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthINNTInnovate BiopharmaceuticalsN/AN/AN/AN/AN/AKMPHZevra TherapeuticsN/AN/AN/AN/AN/ASNNASienna BiopharmaceuticalsN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINNTInnovate BiopharmaceuticalsN/A0.350.35KMPHZevra Therapeutics0.1410.1010.10SNNASienna BiopharmaceuticalsN/A15.2715.27OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINNTInnovate Biopharmaceuticals5.88%KMPHZevra Therapeutics19.39%SNNASienna Biopharmaceuticals17.36%Insider OwnershipCompanyInsider OwnershipINNTInnovate Biopharmaceuticals7.90%KMPHZevra Therapeutics1.10%SNNASienna Biopharmaceuticals27.20%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableINNTInnovate Biopharmaceuticals841.33 millionN/ANot OptionableKMPHZevra Therapeutics2234.51 million34.13 millionOptionableSNNASienna Biopharmaceuticals3930.91 millionN/ANot OptionableINNT, KMPH, and SNNA HeadlinesSourceHeadlineFormer Sienna guard Elisa Mevius commits to Oregon women’s basketballmsn.com - March 27 at 1:08 AMSienna Chirieleison scores 8 times as Trinity girls lax downs Red Land, 14-9pennlive.com - March 27 at 1:08 AMSienna Miller's Missoma earrings are on every A-lister this seasonuk.style.yahoo.com - March 26 at 7:47 AMSienna Miller's affordable earrings are top of our wish listmsn.com - March 25 at 4:45 PMSienna Schreiber, MU's highest-scoring gymnast, chases more perfection in postseasonstltoday.com - March 22 at 8:47 PMThe £13 French ‘miracle cream’ Sienna Miller & Michelle Keegan swear by… that leaves skin soft & plumpthesun.ie - March 15 at 10:14 AMCiara Captures Daughter Sienna Princess Getting Dolled Up For Her 2nd Annual Daddy-Daughter Dance With Russell Wilsonmadamenoire.com - March 15 at 10:14 AMGrandview girls basketball star Sienna Betts named Colorado Gatorade Player of the Yearmsn.com - March 15 at 12:14 AMGirls Basketball: Grandview’s Sienna Betts repeats as Colorado Gatorade POYsentinelcolorado.com - March 14 at 1:48 PMSienna Miller Just Wore A Perfect Rainy Day Outfit, Including One Of Her Favourite High Street Brandsmsn.com - March 12 at 4:13 PMSienna Miller's Missoma earrings are a must-have for the new seasonmsn.com - March 12 at 4:13 PMSienna Miller just broke this age-old fashion rule on date night - and pulled it offhellomagazine.com - March 12 at 9:31 AMSisters Ella and Sienna keep Swifties party goingcoastcommunitynews.com.au - March 11 at 9:46 AMCiara Celebrates Women’s Day With Sienna in Disneyland as Russell Wilson Fights for NFL Futuremsn.com - March 10 at 1:29 PMSienna Miller and Oli Green Step Out Months After Welcoming Baby Girlaol.com - March 10 at 1:15 AMSienna Miller and Boyfriend Oli Green Step Out Months After Welcoming Their Baby Girlusmagazine.com - March 9 at 8:14 PMSienna Miller, 42, and rarely-seen boyfriend Oli Green, 27, make stunning appearance after welcoming baby girlmsn.com - March 8 at 8:42 AMHollyoaks confirms major death twist for Sienna Blake as dastardly James Nightingale goes too farmsn.com - March 7 at 3:29 PMEXCLUSIVE: Issa Rae on Her Mission for Healthy Hair Journeys in New Sienna Naturals Campaignsg.news.yahoo.com - March 5 at 1:04 PMSienna Miller just wore the 'cool girl' coat trend of the seasonmsn.com - March 5 at 1:04 PMFrom Top To Toe, How Sienna Miller Looks That Goodvogue.co.uk - March 5 at 8:03 AMNail Sienna Miller's $2,798 Leather Trench Style for Under $50msn.com - March 4 at 8:44 PMRussell Wilson accompanies 6-year-old Sienna to a daddy-daughter dancenbcwashington.com - March 4 at 3:43 PMNail Sienna Miller’s $2,798 Leather Trench Style for Under $50usmagazine.com - March 4 at 3:43 PMNew MarketBeat Followers Over TimeCompany DescriptionsInnovate BiopharmaceuticalsNASDAQ:INNTInnovate Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company's lead product candidate is INN-202 that has completed Phase IIb clinical trial for the treatment of celiac disease. It also develops INN-108, which has completed Phase I clinical trial to treat mild-to-moderate ulcerative colitis; INN-217 for the treatment of non-alcoholic steatohepatitis and microbiome; and INN-289 to treat crohn's disease, as well as product for the treatment of alcoholic steatohepatitis (ASH). In addition, the company holds rights for INN-329, a formulation of secretin that is used to enhance visualization in magnetic resonance cholangiopancreatography procedures that is in Phase III clinical trial. The company has a research collaboration with Massachusetts General Hospital for the treatment of ASH. Innovate Biopharmaceuticals, Inc. is based in Raleigh, North Carolina.Zevra TherapeuticsNASDAQ:KMPHKemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses on the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.Sienna BiopharmaceuticalsNASDAQ:SNNASienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.